Arlington, MA, United States of America

Jorden Kass

USPTO Granted Patents = 25 


Average Co-Inventor Count = 8.2

ph-index = 9

Forward Citations = 159(Granted Patents)


Location History:

  • Belmont, MA (US) (2017 - 2021)
  • Arlington, MA (US) (2019 - 2024)

Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
25 patents (USPTO):

Title: Innovator Spotlight: Jorden Kass - Pioneering Antiviral Medications

Introduction

Jorden Kass, hailing from Arlington, MA, is a prolific inventor in the field of antiviral medications. With an impressive portfolio of 22 patents, Kass has dedicated his career to developing innovative solutions to combat infectious diseases. His latest patents showcase his commitment to addressing pressing health concerns, particularly in the realm of coronavirus and hepatitis B infections.

Latest Patents

Kass's recent patents include groundbreaking inventions such as Spiropyrrolidine derived antiviral agents. These compounds play a crucial role in inhibiting coronavirus replication, offering new hope in the fight against this global pandemic. Additionally, his Hepatitis B antiviral agents have shown promise in interfering with the lifecycle of the hepatitis B virus, providing effective treatment options for individuals battling HBV infections.

Career Highlights

Currently associated with Enanta Pharmaceuticals, Inc., a leading pharmaceutical company known for its advancements in drug discovery, Kass continues to push the boundaries of antiviral research. His pivotal role in conceptualizing and patenting novel treatments underscores his expertise and dedication to improving public health on a global scale.

Collaborations

In his pursuit of scientific excellence, Kass has collaborated with esteemed colleagues such as Hui Cao and Wei Li. Together, they have synergized their expertise to drive innovation and bring life-changing medications to fruition. This spirit of collaboration underscores Kass's commitment to collective advancements in antiviral therapeutics.

Conclusion

Jorden Kass stands as a beacon of innovation in the field of antiviral medications. His relentless pursuit of novel solutions and unwavering commitment to scientific advancement have positioned him as a key figure in the fight against infectious diseases. With a focus on developing cutting-edge treatments for devastating viruses, Kass's work exemplifies the transformative power of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…